Patent details
EP2056857 Title: PHARMACEUTICAL COMPOSITIONS COMPRISING CCL2 FOR USE IN THE TREATMENT OF INFLAMMATION
Basic Information
- Publication number:
- EP2056857
- PCT Application Number:
- PCT/IL/2007/000806
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP077668366
- PCT Publication Number:
- WO/2008/012796
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PHARMACEUTICAL COMPOSITIONS COMPRISING CCL2 FOR USE IN THE TREATMENT OF INFLAMMATION
- French Title of Invention:
- COMPOSITIONS PHARMACEUTIQUES COMPRENANT CCL2 POUR SON UTILISATION DANS LE TRAITEMENT D'UNE INFLAMMATION
- German Title of Invention:
- PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT CCL2 ZUR VERWENDUNG ZUR BEHANDLUNG VON ENTZÜNDUNGEN
- SPC Number:
Dates
- Filing date:
- 28/06/2007
- Grant date:
- 21/08/2013
- EP Publication Date:
- 21/08/2013
- PCT Publication Date:
- 31/01/2008
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 13/05/2009
- EP B1 Publication Date:
- 21/08/2013
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 28/06/2014
- Expiration date:
- 28/06/2027
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 28/06/2007
- Name:
- YEDA RESEARCH AND DEVELOPMENT CO. LTD.
- Address:
- at the Weizmann Institute of Science, P.O. Box 95, 76100 Rehovot, Israel (IL)
Inventor
1
- Name:
- SHACHAR Idit
- Address:
- Israel (IL)
2
- Name:
- FLAISHON Liat
- Address:
- Israel (IL)
Priority
- Priority Number:
- 832600 P
- Priority Date:
- 24/07/2006
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 38/17;
| Filing date | Document type | Number of pages |
|---|